A novel biomarker for Alzheimer's disease in its asymptomatic phases has been discovered by a recent study headed by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona.
A recent University of Iowa study's findings may aid in the improvement of cognitive impairment in Parkinson's disease (PD) diagnosis as well as the development of novel biomarkers and targeted treatments for the illness's cognitive symptoms.
For Parkinson's disease (PD) patients, a few minutes of data collected from a single electrode put on top of the head may be sufficient to anticipate cognitive issues, including dementia. The results of a recent University of Iowa study may aid in the improvement of cognitive impairment in P
Washington [US], May 6 (ANI): Researchers during a recent study discovered a novel biomarker to identify male patients with COVID-19, who are at the highest risk for ICU admission.